Lebrikizumab (Anti-IL-13)
Lebrikizumab (anti-IL-13) is an humanized IgG4 monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. MW: 145.8 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2954 |
| Sku # | A2954-1mg*25 |
| Pricing | 1mg*25, $2970.00 |